MARKET

FEMY

FEMY

FEMASYS INC
NASDAQ
2.735
-0.245
-8.22%
Opening 14:27 09/08 EDT
OPEN
2.990
PREV CLOSE
2.980
HIGH
3.086
LOW
2.660
VOLUME
141.82K
TURNOVER
--
52 WEEK HIGH
22.20
52 WEEK LOW
2.022
MARKET CAP
22.91M
P/E (TTM)
-0.6195
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at FEMY last week (0831-0904)?
Weekly Report · 1d ago
Femasys Files Prospectus Related To The Offer And Resale From Time To Time By The Selling Stockholders Of Up To An Aggregate Of 28,124,997 Shares Of Common Stock
Benzinga · 4d ago
Weekly Report: what happened at FEMY last week (0824-0828)?
Weekly Report · 08/31 09:26
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 08/28 17:05
Weekly Buzz: GILD, ROIV Win FDA Nod; BHVN, LLY Strike Deal; SYRE Misses Monotherapy Goal
NASDAQ · 08/28 14:42
Femasys Partners With UNC Health To Expand Fertility Care Access
NASDAQ · 08/26 13:48
Femasys announces fertility partnership with UNC Health
TipRanks · 08/26 13:05
Femasys Partners With UNC Health To Introduce Fertility Diagnostics, FemVue And SpermVue, Together With Femaseed Complete Within UNC Health OB/GYN Practice Locations
Benzinga · 08/26 13:04
More
About FEMY
Femasys Inc. is a biomedical company. The Company is focused on addressing the unmet needs of women worldwide with a broad portfolio of in-office, accessible, and therapeutic and diagnostic solutions. The Company has two lead product candidates: FemBloc and FemaSeed. FemBloc is a permanent birth control solution in development. Its permanent birth control solution in development includes its FemBloc system, which features dual intrauterine directional delivery targeting both fallopian tubes with a degradable blended biopolymer. FemaSeed is an artificial insemination infertility treatment. Its artificial insemination solution in development includes its FemaSeed product candidate for artificial insemination, which features single intrauterine directional delivery. It also developed FemCerv, which is an endocervical tissue sampler for cervical cancer diagnosis; FemVue, which is a companion diagnostic for fallopian tube assessment; FemCath, which is an intrauterine catheter, and FemChec.

Webull offers Femasys Inc stock information, including NASDAQ: FEMY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FEMY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading FEMY stock methods without spending real money on the virtual paper trading platform.